Clinical Efficacy and Safety of Ixekizumab for Treatment of Psoriasis A. Azevedo, T. Torres

Comparing the Use of Topical Therapy Along with Anti-IL-17 and Anti-IL-23 to Treat Moderate-to-Severe Psoriasis in the Routine Clinical Practice S. Berenguer-Ruiz, M. Romero-Dávila, M. Aparicio-Domínguez, M. Olivares-Guerrero, E. Daudén, M. Llamas-Velasco

Immune-Mediated Skin Reactions to Tumor Necrosis α Inhibitors: A Review of 30 Cases M. Sin-Soler, J. Romaní, M. Gamissans, N. Riera-Martí, A. Lara, M. Ribera